A previous study (39) applied TPS to determine the tumor size of untreated stage IIIB-IV NSCLC patients who underwent 18F-FDG PET/CT scanning and pulmonary lesion biopsy for PDL1 immunochemistry. This evidence concerns the gene CD274 and neoplasm.